NewsPress Releases

Global Kinetics Corporation’s PKG Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization and Patient-Clinician Converstations in Parkinson’s Disease

7 May 2019 | News, Press Releases,

Data recently presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical study continues enrollment at 10 movement disorder clinics in the U.S.

Global Kinetics today reported data that was recently presented at poster presentation sessions during the 2019 American Academy of Neurology’s (AAN) Annual Meeting in Philadelphia, PA, May 4 – 10, 2019 and the 2019 Parkinson Study Group (PSG) in Phoenix, AZ, April 5 – 8, 2019.  The two posters highlighted how the company’s Personal KinetiGraph (PKG) technology provides clinically meaningful improvements in Parkinson’s disease (PD) symptom assessment, management and medication optimization and also enhanced patient-clinician conversations.

Read the full press release here

Are you interested in learning more?